Harbor Investment Advisory’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Harbor Investment Advisory’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4	Closed	-$129	–	1362
2024 Q1	$129	Buy	+4	New	+$149	﹤0.01%	1307
2021 Q2	–	Sell	-159	Closed	-$12K	–	1275
2021 Q1	$12K	Hold	159	–	–	﹤0.01%	949
2020 Q4	$16K	Hold	159	–	–	﹤0.01%	854
2020 Q3	$23K	Hold	159	–	–	﹤0.01%	701
2020 Q2	$31K	Hold	159	–	–	0.01%	529
2020 Q1	$31K	Buy	+159	New	+$34.2K	0.01%	487

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Harbor Investment Advisory's LKFT Position: Q2 2024 in Review

Harbor Investment Advisory sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2024, closing a stake of 4 shares — an estimated $129 sold.

Harbor Investment Advisory first reported a position in LKFT in Q1 2020 and held it in 6 quarters. The position peaked at $31K in Q2 2020. 85 funds tracked by Wall St. Rank hold LKFT as of Q2 2024.

Harbor Investment Advisory reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2024 after selling out during the quarter.
Harbor Investment Advisory sold 4 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2024, an estimated $129.
Harbor Investment Advisory first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and held it in 6 quarters.
Harbor Investment Advisory's Lakefront Biotherapeutics American Depositary Shares position peaked at $31K in Q2 2020.
85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2024.

Based on Harbor Investment Advisory's 13F filing for Q2 2024, filed 19 Jul 2024.